nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—CA3—pericardium—peritoneum cancer	0.0465	0.0465	CbGeAlD
Nilotinib—KIT—myenteric nerve plexus—peritoneum cancer	0.0456	0.0456	CbGeAlD
Nilotinib—CA9—gall bladder—peritoneum cancer	0.0137	0.0137	CbGeAlD
Nilotinib—CDC42BPB—smooth muscle tissue—peritoneum cancer	0.0116	0.0116	CbGeAlD
Nilotinib—CDC42BPB—decidua—peritoneum cancer	0.0114	0.0114	CbGeAlD
Nilotinib—FRK—lymphoid tissue—peritoneum cancer	0.011	0.011	CbGeAlD
Nilotinib—PDGFRA—gall bladder—peritoneum cancer	0.011	0.011	CbGeAlD
Nilotinib—MAPK8—epithelium—peritoneum cancer	0.0109	0.0109	CbGeAlD
Nilotinib—BLK—lymphoid tissue—peritoneum cancer	0.0106	0.0106	CbGeAlD
Nilotinib—MAPK8—smooth muscle tissue—peritoneum cancer	0.0105	0.0105	CbGeAlD
Nilotinib—EPHB2—lymphoid tissue—peritoneum cancer	0.0105	0.0105	CbGeAlD
Nilotinib—CDC42BPB—uterus—peritoneum cancer	0.00994	0.00994	CbGeAlD
Nilotinib—TIE1—epithelium—peritoneum cancer	0.00943	0.00943	CbGeAlD
Nilotinib—MAP4K1—decidua—peritoneum cancer	0.00934	0.00934	CbGeAlD
Nilotinib—TIE1—smooth muscle tissue—peritoneum cancer	0.00909	0.00909	CbGeAlD
Nilotinib—MAPK8—uterus—peritoneum cancer	0.00899	0.00899	CbGeAlD
Nilotinib—TIE1—decidua—peritoneum cancer	0.00891	0.00891	CbGeAlD
Nilotinib—KIT—gall bladder—peritoneum cancer	0.00878	0.00878	CbGeAlD
Nilotinib—PDGFRB—gall bladder—peritoneum cancer	0.00857	0.00857	CbGeAlD
Nilotinib—MAPK8—lymphoid tissue—peritoneum cancer	0.00838	0.00838	CbGeAlD
Nilotinib—MAPK11—female gonad—peritoneum cancer	0.0082	0.0082	CbGeAlD
Nilotinib—CDC42BPB—female gonad—peritoneum cancer	0.00813	0.00813	CbGeAlD
Nilotinib—BRAF—endometrium—peritoneum cancer	0.00811	0.00811	CbGeAlD
Nilotinib—FRK—liver—peritoneum cancer	0.00809	0.00809	CbGeAlD
Nilotinib—EPHB3—endometrium—peritoneum cancer	0.00805	0.00805	CbGeAlD
Nilotinib—TIE1—uterus—peritoneum cancer	0.00779	0.00779	CbGeAlD
Nilotinib—HCK—decidua—peritoneum cancer	0.00779	0.00779	CbGeAlD
Nilotinib—LYN—lymphoid tissue—peritoneum cancer	0.00773	0.00773	CbGeAlD
Nilotinib—MAP4K1—lymphoid tissue—peritoneum cancer	0.00762	0.00762	CbGeAlD
Nilotinib—BRAF—uterus—peritoneum cancer	0.00747	0.00747	CbGeAlD
Nilotinib—EPHB3—uterus—peritoneum cancer	0.00741	0.00741	CbGeAlD
Nilotinib—HCK—endometrium—peritoneum cancer	0.00739	0.00739	CbGeAlD
Nilotinib—MAPK8—female gonad—peritoneum cancer	0.00735	0.00735	CbGeAlD
Nilotinib—MAPK14—epithelium—peritoneum cancer	0.00691	0.00691	CbGeAlD
Nilotinib—CDC42BPB—liver—peritoneum cancer	0.00682	0.00682	CbGeAlD
Nilotinib—HCK—uterus—peritoneum cancer	0.00681	0.00681	CbGeAlD
Nilotinib—MAPK14—smooth muscle tissue—peritoneum cancer	0.00666	0.00666	CbGeAlD
Nilotinib—EPHB4—epithelium—peritoneum cancer	0.00655	0.00655	CbGeAlD
Nilotinib—MAPK14—decidua—peritoneum cancer	0.00653	0.00653	CbGeAlD
Nilotinib—FGR—decidua—peritoneum cancer	0.0065	0.0065	CbGeAlD
Nilotinib—LCK—decidua—peritoneum cancer	0.0065	0.0065	CbGeAlD
Nilotinib—EPHA2—epithelium—peritoneum cancer	0.00643	0.00643	CbGeAlD
Nilotinib—TIE1—female gonad—peritoneum cancer	0.00638	0.00638	CbGeAlD
Nilotinib—HCK—lymphoid tissue—peritoneum cancer	0.00635	0.00635	CbGeAlD
Nilotinib—EPHB4—smooth muscle tissue—peritoneum cancer	0.00631	0.00631	CbGeAlD
Nilotinib—TEK—epithelium—peritoneum cancer	0.00627	0.00627	CbGeAlD
Nilotinib—EPHA4—uterus—peritoneum cancer	0.00619	0.00619	CbGeAlD
Nilotinib—EPHB4—decidua—peritoneum cancer	0.00619	0.00619	CbGeAlD
Nilotinib—FGR—endometrium—peritoneum cancer	0.00617	0.00617	CbGeAlD
Nilotinib—MAPK8—liver—peritoneum cancer	0.00617	0.00617	CbGeAlD
Nilotinib—CA3—uterus—peritoneum cancer	0.00612	0.00612	CbGeAlD
Nilotinib—BRAF—female gonad—peritoneum cancer	0.00611	0.00611	CbGeAlD
Nilotinib—EPHA2—decidua—peritoneum cancer	0.00607	0.00607	CbGeAlD
Nilotinib—EPHB3—female gonad—peritoneum cancer	0.00606	0.00606	CbGeAlD
Nilotinib—TEK—smooth muscle tissue—peritoneum cancer	0.00604	0.00604	CbGeAlD
Nilotinib—BLK—lymph node—peritoneum cancer	0.00598	0.00598	CbGeAlD
Nilotinib—TEK—decidua—peritoneum cancer	0.00592	0.00592	CbGeAlD
Nilotinib—EPHB4—endometrium—peritoneum cancer	0.00587	0.00587	CbGeAlD
Nilotinib—EPHA2—endometrium—peritoneum cancer	0.00576	0.00576	CbGeAlD
Nilotinib—MAPK14—uterus—peritoneum cancer	0.00571	0.00571	CbGeAlD
Nilotinib—LYN—liver—peritoneum cancer	0.00569	0.00569	CbGeAlD
Nilotinib—LCK—uterus—peritoneum cancer	0.00569	0.00569	CbGeAlD
Nilotinib—EPHB6—decidua—peritoneum cancer	0.00566	0.00566	CbGeAlD
Nilotinib—TEK—endometrium—peritoneum cancer	0.00562	0.00562	CbGeAlD
Nilotinib—HCK—female gonad—peritoneum cancer	0.00557	0.00557	CbGeAlD
Nilotinib—ABL2—female gonad—peritoneum cancer	0.00554	0.00554	CbGeAlD
Nilotinib—PDGFRA—smooth muscle tissue—peritoneum cancer	0.00547	0.00547	CbGeAlD
Nilotinib—EPHB4—uterus—peritoneum cancer	0.00541	0.00541	CbGeAlD
Nilotinib—EPHB6—endometrium—peritoneum cancer	0.00537	0.00537	CbGeAlD
Nilotinib—PDGFRA—decidua—peritoneum cancer	0.00536	0.00536	CbGeAlD
Nilotinib—TIE1—liver—peritoneum cancer	0.00535	0.00535	CbGeAlD
Nilotinib—MAPK14—lymphoid tissue—peritoneum cancer	0.00532	0.00532	CbGeAlD
Nilotinib—FGR—lymphoid tissue—peritoneum cancer	0.0053	0.0053	CbGeAlD
Nilotinib—MAPK11—lymph node—peritoneum cancer	0.00527	0.00527	CbGeAlD
Nilotinib—CDC42BPB—lymph node—peritoneum cancer	0.00523	0.00523	CbGeAlD
Nilotinib—CA2—gall bladder—peritoneum cancer	0.0052	0.0052	CbGeAlD
Nilotinib—TEK—uterus—peritoneum cancer	0.00518	0.00518	CbGeAlD
Nilotinib—BRAF—liver—peritoneum cancer	0.00513	0.00513	CbGeAlD
Nilotinib—EPHA4—female gonad—peritoneum cancer	0.00507	0.00507	CbGeAlD
Nilotinib—EPHA3—lymph node—peritoneum cancer	0.00496	0.00496	CbGeAlD
Nilotinib—EPHA2—lymphoid tissue—peritoneum cancer	0.00495	0.00495	CbGeAlD
Nilotinib—MAP2K5—decidua—peritoneum cancer	0.00484	0.00484	CbGeAlD
Nilotinib—TEK—lymphoid tissue—peritoneum cancer	0.00483	0.00483	CbGeAlD
Nilotinib—CSF1R—smooth muscle tissue—peritoneum cancer	0.00482	0.00482	CbGeAlD
Nilotinib—MAPK8—lymph node—peritoneum cancer	0.00473	0.00473	CbGeAlD
Nilotinib—CSF1R—decidua—peritoneum cancer	0.00472	0.00472	CbGeAlD
Nilotinib—PDGFRA—uterus—peritoneum cancer	0.00469	0.00469	CbGeAlD
Nilotinib—HCK—liver—peritoneum cancer	0.00467	0.00467	CbGeAlD
Nilotinib—MAPK14—female gonad—peritoneum cancer	0.00467	0.00467	CbGeAlD
Nilotinib—LCK—female gonad—peritoneum cancer	0.00465	0.00465	CbGeAlD
Nilotinib—FGR—female gonad—peritoneum cancer	0.00465	0.00465	CbGeAlD
Nilotinib—ABL2—liver—peritoneum cancer	0.00464	0.00464	CbGeAlD
Nilotinib—MAP2K5—endometrium—peritoneum cancer	0.00459	0.00459	CbGeAlD
Nilotinib—KIT—epithelium—peritoneum cancer	0.00454	0.00454	CbGeAlD
Nilotinib—CSF1R—endometrium—peritoneum cancer	0.00448	0.00448	CbGeAlD
Nilotinib—PDGFRB—epithelium—peritoneum cancer	0.00443	0.00443	CbGeAlD
Nilotinib—EPHB4—female gonad—peritoneum cancer	0.00443	0.00443	CbGeAlD
Nilotinib—KIT—smooth muscle tissue—peritoneum cancer	0.00437	0.00437	CbGeAlD
Nilotinib—PDGFRA—lymphoid tissue—peritoneum cancer	0.00437	0.00437	CbGeAlD
Nilotinib—EPHA2—female gonad—peritoneum cancer	0.00434	0.00434	CbGeAlD
Nilotinib—MAP4K1—lymph node—peritoneum cancer	0.0043	0.0043	CbGeAlD
Nilotinib—KIT—decidua—peritoneum cancer	0.00429	0.00429	CbGeAlD
Nilotinib—PDGFRB—smooth muscle tissue—peritoneum cancer	0.00427	0.00427	CbGeAlD
Nilotinib—TEK—female gonad—peritoneum cancer	0.00424	0.00424	CbGeAlD
Nilotinib—CA3—liver—peritoneum cancer	0.0042	0.0042	CbGeAlD
Nilotinib—PDGFRB—decidua—peritoneum cancer	0.00419	0.00419	CbGeAlD
Nilotinib—CSF1R—uterus—peritoneum cancer	0.00413	0.00413	CbGeAlD
Nilotinib—TIE1—lymph node—peritoneum cancer	0.0041	0.0041	CbGeAlD
Nilotinib—KIT—endometrium—peritoneum cancer	0.00407	0.00407	CbGeAlD
Nilotinib—EPHB6—female gonad—peritoneum cancer	0.00405	0.00405	CbGeAlD
Nilotinib—PDGFRB—endometrium—peritoneum cancer	0.00398	0.00398	CbGeAlD
Nilotinib—BRAF—lymph node—peritoneum cancer	0.00393	0.00393	CbGeAlD
Nilotinib—MAPK14—liver—peritoneum cancer	0.00392	0.00392	CbGeAlD
Nilotinib—LCK—liver—peritoneum cancer	0.0039	0.0039	CbGeAlD
Nilotinib—FGR—liver—peritoneum cancer	0.0039	0.0039	CbGeAlD
Nilotinib—EPHB3—lymph node—peritoneum cancer	0.0039	0.0039	CbGeAlD
Nilotinib—CSF1R—lymphoid tissue—peritoneum cancer	0.00385	0.00385	CbGeAlD
Nilotinib—PDGFRA—female gonad—peritoneum cancer	0.00384	0.00384	CbGeAlD
Nilotinib—CA14—liver—peritoneum cancer	0.00381	0.00381	CbGeAlD
Nilotinib—ABL1—smooth muscle tissue—peritoneum cancer	0.00381	0.00381	CbGeAlD
Nilotinib—KIT—uterus—peritoneum cancer	0.00375	0.00375	CbGeAlD
Nilotinib—ABL1—decidua—peritoneum cancer	0.00373	0.00373	CbGeAlD
Nilotinib—EPHB4—liver—peritoneum cancer	0.00371	0.00371	CbGeAlD
Nilotinib—PDGFRB—uterus—peritoneum cancer	0.00366	0.00366	CbGeAlD
Nilotinib—EPHA2—liver—peritoneum cancer	0.00364	0.00364	CbGeAlD
Nilotinib—HCK—lymph node—peritoneum cancer	0.00358	0.00358	CbGeAlD
Nilotinib—ABL2—lymph node—peritoneum cancer	0.00356	0.00356	CbGeAlD
Nilotinib—TEK—liver—peritoneum cancer	0.00355	0.00355	CbGeAlD
Nilotinib—ABL1—endometrium—peritoneum cancer	0.00354	0.00354	CbGeAlD
Nilotinib—KIT—lymphoid tissue—peritoneum cancer	0.0035	0.0035	CbGeAlD
Nilotinib—MAP2K5—female gonad—peritoneum cancer	0.00346	0.00346	CbGeAlD
Nilotinib—PDGFRB—lymphoid tissue—peritoneum cancer	0.00342	0.00342	CbGeAlD
Nilotinib—CSF1R—female gonad—peritoneum cancer	0.00338	0.00338	CbGeAlD
Nilotinib—ABL1—uterus—peritoneum cancer	0.00327	0.00327	CbGeAlD
Nilotinib—EPHA4—lymph node—peritoneum cancer	0.00326	0.00326	CbGeAlD
Nilotinib—PDGFRA—liver—peritoneum cancer	0.00322	0.00322	CbGeAlD
Nilotinib—CA3—lymph node—peritoneum cancer	0.00322	0.00322	CbGeAlD
Nilotinib—CA1—lymphoid tissue—peritoneum cancer	0.0032	0.0032	CbGeAlD
Nilotinib—UGT1A1—liver—peritoneum cancer	0.00307	0.00307	CbGeAlD
Nilotinib—KIT—female gonad—peritoneum cancer	0.00307	0.00307	CbGeAlD
Nilotinib—ABL1—lymphoid tissue—peritoneum cancer	0.00304	0.00304	CbGeAlD
Nilotinib—MAPK14—lymph node—peritoneum cancer	0.003	0.003	CbGeAlD
Nilotinib—PDGFRB—female gonad—peritoneum cancer	0.003	0.003	CbGeAlD
Nilotinib—LCK—lymph node—peritoneum cancer	0.00299	0.00299	CbGeAlD
Nilotinib—FGR—lymph node—peritoneum cancer	0.00299	0.00299	CbGeAlD
Nilotinib—MAP2K5—liver—peritoneum cancer	0.0029	0.0029	CbGeAlD
Nilotinib—EPHB4—lymph node—peritoneum cancer	0.00285	0.00285	CbGeAlD
Nilotinib—CSF1R—liver—peritoneum cancer	0.00283	0.00283	CbGeAlD
Nilotinib—EPHA2—lymph node—peritoneum cancer	0.00279	0.00279	CbGeAlD
Nilotinib—TEK—lymph node—peritoneum cancer	0.00272	0.00272	CbGeAlD
Nilotinib—CA2—epithelium—peritoneum cancer	0.00269	0.00269	CbGeAlD
Nilotinib—ABL1—female gonad—peritoneum cancer	0.00267	0.00267	CbGeAlD
Nilotinib—EPHB6—lymph node—peritoneum cancer	0.0026	0.0026	CbGeAlD
Nilotinib—CA2—smooth muscle tissue—peritoneum cancer	0.00259	0.00259	CbGeAlD
Nilotinib—KIT—liver—peritoneum cancer	0.00257	0.00257	CbGeAlD
Nilotinib—CA2—decidua—peritoneum cancer	0.00254	0.00254	CbGeAlD
Nilotinib—PDGFRB—liver—peritoneum cancer	0.00251	0.00251	CbGeAlD
Nilotinib—PDGFRA—lymph node—peritoneum cancer	0.00247	0.00247	CbGeAlD
Nilotinib—ABCG2—decidua—peritoneum cancer	0.00235	0.00235	CbGeAlD
Nilotinib—CA1—liver—peritoneum cancer	0.00235	0.00235	CbGeAlD
Nilotinib—CYP2C8—endometrium—peritoneum cancer	0.0023	0.0023	CbGeAlD
Nilotinib—ABL1—liver—peritoneum cancer	0.00224	0.00224	CbGeAlD
Nilotinib—ABCG2—endometrium—peritoneum cancer	0.00223	0.00223	CbGeAlD
Nilotinib—MAP2K5—lymph node—peritoneum cancer	0.00223	0.00223	CbGeAlD
Nilotinib—CA4—female gonad—peritoneum cancer	0.00219	0.00219	CbGeAlD
Nilotinib—CSF1R—lymph node—peritoneum cancer	0.00217	0.00217	CbGeAlD
Nilotinib—CA2—lymphoid tissue—peritoneum cancer	0.00207	0.00207	CbGeAlD
Nilotinib—ABCG2—uterus—peritoneum cancer	0.00206	0.00206	CbGeAlD
Nilotinib—KIT—lymph node—peritoneum cancer	0.00197	0.00197	CbGeAlD
Nilotinib—PDGFRB—lymph node—peritoneum cancer	0.00193	0.00193	CbGeAlD
Nilotinib—CA2—female gonad—peritoneum cancer	0.00182	0.00182	CbGeAlD
Nilotinib—CA1—lymph node—peritoneum cancer	0.0018	0.0018	CbGeAlD
Nilotinib—CYP2B6—lymphoid tissue—peritoneum cancer	0.00177	0.00177	CbGeAlD
Nilotinib—ABL1—lymph node—peritoneum cancer	0.00172	0.00172	CbGeAlD
Nilotinib—ABCG2—female gonad—peritoneum cancer	0.00168	0.00168	CbGeAlD
Nilotinib—CA2—liver—peritoneum cancer	0.00153	0.00153	CbGeAlD
Nilotinib—CYP2C8—liver—peritoneum cancer	0.00145	0.00145	CbGeAlD
Nilotinib—ABCG2—liver—peritoneum cancer	0.00141	0.00141	CbGeAlD
Nilotinib—CA4—lymph node—peritoneum cancer	0.00141	0.00141	CbGeAlD
Nilotinib—CYP2B6—liver—peritoneum cancer	0.0013	0.0013	CbGeAlD
Nilotinib—CYP2C9—liver—peritoneum cancer	0.00129	0.00129	CbGeAlD
Nilotinib—ABCB1—epithelium—peritoneum cancer	0.00123	0.00123	CbGeAlD
Nilotinib—CA2—lymph node—peritoneum cancer	0.00117	0.00117	CbGeAlD
Nilotinib—ABCB1—decidua—peritoneum cancer	0.00116	0.00116	CbGeAlD
Nilotinib—CYP2D6—female gonad—peritoneum cancer	0.00115	0.00115	CbGeAlD
Nilotinib—ABCB1—endometrium—peritoneum cancer	0.0011	0.0011	CbGeAlD
Nilotinib—ABCG2—lymph node—peritoneum cancer	0.00108	0.00108	CbGeAlD
Nilotinib—ABCB1—uterus—peritoneum cancer	0.00102	0.00102	CbGeAlD
Nilotinib—CYP3A4—liver—peritoneum cancer	0.000984	0.000984	CbGeAlD
Nilotinib—CYP2D6—liver—peritoneum cancer	0.000968	0.000968	CbGeAlD
Nilotinib—ABCB1—lymphoid tissue—peritoneum cancer	0.000947	0.000947	CbGeAlD
Nilotinib—ABCB1—female gonad—peritoneum cancer	0.000831	0.000831	CbGeAlD
Nilotinib—ABCB1—liver—peritoneum cancer	0.000697	0.000697	CbGeAlD
Nilotinib—ABCB1—lymph node—peritoneum cancer	0.000534	0.000534	CbGeAlD
